Clinical Trial Update: A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating cytotoxic T cells to augment autologous stem cell transplantation for acute myeloid leukemia; the study status is terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Thomas A. Lane, MD | Conditions: AML | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-02-22